scispace - formally typeset
V

Virginia Motilva

Researcher at University of Seville

Publications -  105
Citations -  4390

Virginia Motilva is an academic researcher from University of Seville. The author has contributed to research in topics: Colitis & Myeloperoxidase. The author has an hindex of 35, co-authored 103 publications receiving 3897 citations. Previous affiliations of Virginia Motilva include Central University of Ecuador.

Papers
More filters
Journal ArticleDOI

Evidence for protective and antioxidant properties of rutin, a natural flavone, against ethanol induced gastric lesions.

TL;DR: The results suggest that the gastroprotective effect of rutin in this experimental model appears through an anti-lipoperoxidants effect, and also by enhancement of the anti-oxidant enzymatic activity.
Journal ArticleDOI

Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis.

TL;DR: It is suggested that inhibition of p38 MAPK signaling by curcumin could explain the reduced COX-2 and iNOS immunosignals and the nitrite production in colonic mucosa reducing the development of chronic experimental colitis.
Journal ArticleDOI

Mediterranean diet and health: biological importance of olive oil.

TL;DR: It has been demonstrated that a diet rich in olive oil is associated with a high percentage of gastric ulcer healing and affords a higher resistance against non steroidal antiinflammatory drugs-induced gastric Ulcerogenesis.
Journal ArticleDOI

Bioactive Compounds Isolated from Microalgae in Chronic Inflammation and Cancer.

TL;DR: Main mechanisms of actions of these compounds in the chemoprevention of these cancers include suppression of cell proliferation, induction of apoptosis, stimulation of antimetastatic and antiangiogenic responses and increased antioxidant and anti-inflammatory activity.
Journal ArticleDOI

Antiulcer and gastroprotective effects of quercetin: a gross and histologic study.

TL;DR: The histomorphometric evaluation of the gastric damage confirmed a significant increase in mucus production accompanied by a parallel reduction of gastric lesions with the highest dose of quercetin tested, which was most effective in necrosis prevention.